Inv16 p13q22 t1616p13q22 Gene Rearrangement Qualitative PCR Test sale cost 980 AED
FISH - 11q23 or LSI MLL Gene Breakapart Test sale cost 950 AED FISH - 11q23 or LSI MLL Gene Breakapart Test Cost 1,120 د.إ Original price was: 1,120 د.إ.950 د.إCurrent price is: 950 د.إ.
Epstein-Barr Virus Early RNA EBER-ISH In-Situ-Hybridization Test sale cost 970 AED Epstein-Barr Virus Early RNA EBER-ISH In-Situ-Hybridization Test Cost 1,080 د.إ Original price was: 1,080 د.إ.970 د.إCurrent price is: 970 د.إ.
Sale!

Inv16 p13q22 t1616p13q22 Gene Rearrangement Qualitative PCR Test Cost

Original price was: 1,090 د.إ.Current price is: 980 د.إ.

-10%

The Inv16 p13q22 t(16;16)(p13;q22) Gene Rearrangement Qualitative PCR Test is a specialized diagnostic procedure designed to detect a specific chromosomal abnormality known as inversion 16 or the translocation between chromosome 16 at bands p13 and q22. This genetic rearrangement is commonly associated with certain types of blood cancers, particularly acute myeloid leukemia (AML). The test employs Polymerase Chain Reaction (PCR) technology, a highly sensitive and precise method for amplifying and detecting specific DNA sequences, allowing for the identification of the inv(16) or t(16;16) rearrangements.

Performed at DNA Labs UAE, a leading facility in genetic testing, this test is crucial for the diagnosis, prognosis, and treatment planning for patients suspected of having AML or related hematologic disorders. By identifying the presence of this genetic anomaly, healthcare providers can tailor treatment strategies more effectively, potentially improving patient outcomes.

The cost of the Inv16 p13q22 t(16;16)(p13;q22) Gene Rearrangement Qualitative PCR Test at DNA Labs UAE is 980 AED. This price reflects the sophisticated nature of the testing technology and the expertise required to interpret the results accurately. Patients and healthcare professionals considering this test should consult with their medical team to understand its implications fully and how it fits into the broader diagnostic and treatment plan.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Inv16 p13q22 t1616p13q22 GENE REARRANGEMENT QUALITATIVE PCR Test

Test Cost: AED 980.0

Test Components:

  • Sample Condition: 3 mL (2 mL min.) whole blood / Bone Marrow from 1 Lavender Top (EDTA) tube. Ship refrigerated. DO NOT FREEZE.
  • Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.

Report Delivery:

Sample collected on Mon / Thu by 11 am will have the report delivered on Wed / Sat.

Method:

Real Time PCR

Test Type:

Cancer

Doctor:

Hematologist, Oncologist

Test Department:

MOLECULAR DIAGNOSTICS

Pre Test Information:

Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.

Test Details:

The Inv16 (p13q22) / t(1616)(p13q22) gene rearrangement qualitative PCR test is a diagnostic test used to detect specific genetic rearrangements in a patient’s DNA. This test is commonly used in the diagnosis of certain types of leukemia, specifically acute myeloid leukemia (AML) with inv(16) or t(16;16) cytogenetic abnormalities.

The inv(16) or t(16;16) cytogenetic abnormalities involve a rearrangement of genetic material between chromosomes 16 and result in the fusion of two genes: CBFB (core-binding factor subunit beta) and MYH11 (myosin heavy chain 11). This fusion gene is known as CBFB-MYH11 and is associated with a specific subtype of AML called acute myelomonocytic leukemia with eosinophilia (AML-M4Eo).

The Inv16 (p13q22) / t(1616)(p13q22) gene rearrangement qualitative PCR test uses polymerase chain reaction (PCR) technology to amplify and detect the presence of the CBFB-MYH11 fusion gene in a patient’s DNA sample. This test can help confirm the diagnosis of AML-M4Eo and guide treatment decisions.

It is important to note that this test is a qualitative PCR test, which means it can determine the presence or absence of the gene rearrangement but does not provide information on the quantity or level of the rearrangement. Quantitative PCR tests may be used to measure the level of gene rearrangement, which can be helpful in monitoring treatment response and disease progression.

Overall, the Inv16 (p13q22) / t(1616)(p13q22) gene rearrangement qualitative PCR test is a valuable tool in the diagnosis and management of certain types of leukemia, providing important information for treatment decisions and prognosis.

Test Name Inv16 p13q22 t1616p13q22 GENE REARRANGEMENT QUALITATIVE PCR Test
Components
Price 980.0 AED
Sample Condition 3 mL (2 mL min.) whole blood \/ Bone Marrow from 1 Lavender Top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.
Report Delivery SampleMon / Thu by 11 am; Report Wed / Sat
Method Real Time PCR
Test type Cancer
Doctor Hematologist, Oncologist
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information Duly filled Genomics Clinical Information Requisition Form (Form 20) is mandatory.
Test Details

The Inv16 (p13q22) / t(1616)(p13q22) gene rearrangement qualitative PCR test is a diagnostic test used to detect specific genetic rearrangements in a patient’s DNA. This test is commonly used in the diagnosis of certain types of leukemia, specifically acute myeloid leukemia (AML) with inv(16) or t(16;16) cytogenetic abnormalities.

The inv(16) or t(16;16) cytogenetic abnormalities involve a rearrangement of genetic material between chromosomes 16 and result in the fusion of two genes: CBFB (core-binding factor subunit beta) and MYH11 (myosin heavy chain 11). This fusion gene is known as CBFB-MYH11 and is associated with a specific subtype of AML called acute myelomonocytic leukemia with eosinophilia (AML-M4Eo).

The Inv16 (p13q22) / t(1616)(p13q22) gene rearrangement qualitative PCR test uses polymerase chain reaction (PCR) technology to amplify and detect the presence of the CBFB-MYH11 fusion gene in a patient’s DNA sample. This test can help confirm the diagnosis of AML-M4Eo and guide treatment decisions.

It is important to note that this test is a qualitative PCR test, which means it can determine the presence or absence of the gene rearrangement but does not provide information on the quantity or level of the rearrangement. Quantitative PCR tests may be used to measure the level of gene rearrangement, which can be helpful in monitoring treatment response and disease progression.

Overall, the Inv16 (p13q22) / t(1616)(p13q22) gene rearrangement qualitative PCR test is a valuable tool in the diagnosis and management of certain types of leukemia, providing important information for treatment decisions and prognosis.

SKU: TEST-5860 Category:

Related products